Platelet-Derived Growth Factor-Mediated Gliomagenesis and Brain Tumor Recruitment

Neurosurgery Clinics of North America

Volumn 18, Issue 1, 2007, Pages 39-58

  Fomchenko, Elena I ^a   Holland, Eric C ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB; JANUS KINASE; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C GAMMA; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR C; PLATELET DERIVED GROWTH FACTOR D; PROTEIN TYROSINE KINASE;

ANGIOGENESIS; ASTROCYTOMA CELL; BRAIN TUMOR; CANCER STEM CELL; CANCER SURGERY; CARCINOGENESIS; CELL DIFFERENTIATION; CELL LINEAGE; CELL POPULATION; CELL PROLIFERATION; CELL STRUCTURE; GENE STRUCTURE; GLIOMA; GLIOMA CELL; HUMAN; INTRACRANIAL TUMOR; NEURAL STEM CELL; NONHUMAN; OLIGODENDROGLIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; TUMOR CELL; TUMOR CELL LINE; TUMOR GROWTH; TUMOR RECURRENCE; TUMOR RESISTANCE; XENOGRAFT;

ANIMALS; BRAIN NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; PLATELET-DERIVED GROWTH FACTOR; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 33846466076     PISSN: 10423680     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nec.2006.10.006     Document Type: Review

References (179)

1. Ross R., Glomset J., Kariya B., et al. A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci USA 71 4 (1974) 1207-1210
2. Heldin C.H., and Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 79 4 (1999) 1283-1316
3. Betsholtz C., Karlsson L., and Lindahl P. Developmental roles of platelet-derived growth factors. Bioessays 23 6 (2001) 494-507
4. Dalla-Favera R., Gelmann E.P., Gallo R.C., et al. A human onc gene homologous to the transforming gene (v-sis) of simian sarcoma virus. Nature 292 5818 (1981) 31-35
5. Ostman A. PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma. Cytokine Growth Factor Rev 15 4 (2004) 275-286
6. Fredriksson L., Li H., and Eriksson U. The PDGF family: four gene products form five dimeric isoforms. Cytokine Growth Factor Rev 15 4 (2004) 197-204
7. Joukov V., Kaipainen A., Jeltsch M., et al. Vascular endothelial growth factors VEGF-B and VEGF-C. J Cell Physiol 173 2 (1997) 211-215
8. Betsholtz C., Johnsson A., Heldin C.H., et al. cDNA sequence and chromosomal localization of human platelet-derived growth factor A-chain and its expression in tumour cell lines. Nature 320 6064 (1986) 695-699
9. Bonthron D.T., Sultan P., and Collins T. Structure of the murine c-sis proto-oncogene (Sis, PDGFB) encoding the B chain of platelet-derived growth factor. Genomics 10 1 (1991) 287-292
10. Uutela M., Lauren J., Bergsten E., et al. Chromosomal location, exon structure, and vascular expression patterns of the human PDGFC and PDGFC genes. Circulation 103 18 (2001) 2242-2247
11. LaRochelle W.J., May-Siroff M., Robbins K.C., et al. A novel mechanism regulating growth factor association with the cell surface: identification of a PDGF retention domain. Genes Dev 5 7 (1991) 1191-1199
12. Ostman A., Andersson M., Betsholtz C., et al. Identification of a cell retention signal in the B-chain of platelet-derived growth factor and in the long splice version of the A-chain. Cell Regul 2 7 (1991) 503-512
13. Feyzi E., Lustig F., Fager G., et al. Characterization of heparin and heparan sulfate domains binding to the long splice variant of platelet-derived growth factor A chain. J Biol Chem 272 9 (1997) 5518-5524
14. Li X., Ponten A., Aase K., et al. PDGF-C is a new protease-activated ligand for the PDGF alpha-receptor. Nat Cell Biol 2 5 (2000) 302-309
15. Bergsten E., Uutela M., Li X., et al. PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor. Nat Cell Biol 3 5 (2001) 512-516
16. Fredriksson L., Li H., Fieber C., et al. Tissue plasminogen activator is a potent activator of PDGF-CC. EMBO J 23 19 (2004) 3793-3802
17. Reigstad L.J., Varhaug J.E., and Lillehaug J.R. Structural and functional specificities of PDGF-C and PDGF-D, the novel members of the platelet-derived growth factors family. FEBS J 272 22 (2005) 5723-5741
18. Heidaran M.A., Beeler J.F., Yu J.C., et al. Differences in substrate specificities of alpha and beta platelet-derived growth factor (PDGF) receptors. Correlation with their ability to mediate PDGF transforming functions. J Biol Chem 268 13 (1993) 9287-9295
19. Klinghoffer R.A., Mueting-Nelsen P.F., Faerman A., et al. The two PDGF receptors maintain conserved signaling in vivo despite divergent embryological functions. Mol Cell 7 2 (2001) 343-354
20. Ding H., Roncari L., Shannon P., et al. Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas. Cancer Res 61 9 (2001) 3826-3836
21. Holland E.C., Celestino J., Dai C., et al. Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat Genet 25 1 (2000) 55-57
22. Rajasekhar V.K., Viale A., Socci N.D., et al. Oncogenic Ras and Akt signaling contribute to glioblastoma formation by differential recruitment of existing mRNAs to polysomes. Mol Cell 12 4 (2003) 889-901
23. Seoane J., Le H.V., Shen L., et al. Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell 117 2 (2004) 211-223
24. Valius M., and Kazlauskas A. Phospholipase C-gamma 1 and phosphatidylinositol 3 kinase are the downstream mediators of the PDGF receptor's mitogenic signal. Cell 73 2 (1993) 321-334
25. Khoshyomn S., Penar P.L., Rossi J., et al. Inhibition of phospholipase C-gamma1 activation blocks glioma cell motility and invasion of fetal rat brain aggregates. Neurosurgery 44 3 (1999) 568-577 [discussion: 577-8]
26. da Rocha A.B., Mans D.R., Regner A., et al. Targeting protein kinase C: new therapeutic opportunities against high-grade malignant gliomas?. Oncologist 7 1 (2002) 17-33
27. Wolf R.M., Wilkes J.J., Chao M.V., et al. Tyrosine phosphorylation of p190 RhoGAP by Fyn regulates oligodendrocyte differentiation. J Neurobiol 49 1 (2001) 62-78
28. Liang X., Draghi N.A., and Resh M.D. Signaling from integrins to Fyn to Rho family GTPases regulates morphologic differentiation of oligodendrocytes. J Neurosci 24 32 (2004) 7140-7149
29. Suetsugu S., Yamazaki D., Kurisu S., et al. Differential roles of WAVE1 and WAVE2 in dorsal and peripheral ruffle formation for fibroblast cell migration. Dev Cell 5 4 (2003) 595-609
30. Bromann P.A., Korkaya H., and Courtneidge S.A. The interplay between Src family kinases and receptor tyrosine kinases. Oncogene 23 48 (2004) 7957-7968
31. Vignais M.L., Sadowski H.B., Watling D., et al. Platelet-derived growth factor induces phosphorylation of multiple JAK family kinases and STAT proteins. Mol Cell Biol 16 4 (1996) 1759-1769
32. Bonni A., Sun Y., Nadal-Vicens M., et al. Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway. Science 278 5337 (1997) 477-483
33. Dai C., Lyustikman Y., Shih A., et al. The characteristics of astrocytomas and oligodendrogliomas are caused by two distinct and interchangeable signaling formats. Neoplasia 7 4 (2005) 397-406
34. Orr-Urtreger A., and Lonai P. Platelet-derived growth factor-A and its receptor are expressed in separate, but adjacent cell layers of the mouse embryo. Development 115 4 (1992) 1045-1058
35. Karlsson L., Lindahl P., Heath J.K., et al. Abnormal gastrointestinal development in PDGF-A and PDGFR-(alpha) deficient mice implicates a novel mesenchymal structure with putative instructive properties in villus morphogenesis. Development 127 16 (2000) 3457-3466
36. Lindahl P., Karlsson L., Hellstrom M., et al. Alveogenesis failure in PDGF-A-deficient mice is coupled to lack of distal spreading of alveolar smooth muscle cell progenitors during lung development. Development 124 20 (1997) 3943-3953
37. Karlsson L., Bondjers C., and Betsholtz C. Roles for PDGF-A and sonic hedgehog in development of mesenchymal components of the hair follicle. Development 126 12 (1999) 2611-2621
38. Hellstrom M., Kalen M., Lindahl P., et al. Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development 126 14 (1999) 3047-3055
39. Aase K., Abramsson A., Karlsson L., et al. Expression analysis of PDGF-C in adult and developing mouse tissues. Mech Dev 110 1-2 (2002) 187-191
40. Hamada T., Ui-Tei K., Imaki J., et al. The expression of SCDGF/PDGF-C/fallotein and SCDGF-B/PDGF-D in the rat central nervous system. Mech Dev 112 1-2 (2002) 161-164
41. Yeh H.J., Ruit K.G., Wang Y.X., et al. PDGF A-chain gene is expressed by mammalian neurons during development and in maturity. Cell 64 1 (1991) 209-216
42. Sasahara M., Fries J.W., Raines E.W., et al. PDGF B-chain in neurons of the central nervous system, posterior pituitary, and in a transgenic model. Cell 64 1 (1991) 217-227
43. Rorsman F., Leveen P., and Betsholtz C. Platelet-derived growth factor (PDGF) A-chain mRNA heterogeneity generated by the use of alternative promoters and alternative polyadenylation sites. Growth Factors 7 3 (1992) 241-251
44. Horvath P., Suganuma A., Inaba M., et al. Multiple elements in the 5′ untranslated region down-regulate c-sis messenger RNA translation. Cell Growth Differ 6 9 (1995) 1103-1110
45. Sasahara M., Amano S., Sato H., et al. Normal developing rat brain expresses a platelet-derived growth factor B chain (c-sis) mRNA truncated at the 5′ end. Oncogene 16 12 (1998) 1571-1578
46. Pringle N.P., Mudhar H.S., Collarini E.J., et al. PDGF receptors in the rat CNS: during late neurogenesis, PDGF alpha-receptor expression appears to be restricted to glial cells of the oligodendrocyte lineage. Development 115 2 (1992) 535-551
47. Fruttiger M., Karlsson L., Hall A.C., et al. Defective oligodendrocyte development and severe hypomyelination in PDGF-A knockout mice. Development 126 3 (1999) 457-467
48. Calver A.R., Hall A.C., Yu W.P., et al. Oligodendrocyte population dynamics and the role of PDGF in vivo. Neuron 20 5 (1998) 869-882
49. Klinghoffer R.A., Hamilton T.G., Hoch R., et al. An allelic series at the PDGFalphaR locus indicates unequal contributions of distinct signaling pathways during development. Dev Cell 2 1 (2002) 103-113
50. Leveen P., Pekny M., Gebre-Medhin S., et al. Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev 8 16 (1994) 1875-1887
51. Cao R., Brakenhielm E., Pawliuk R., et al. Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nat Med 9 5 (2003) 604-613
52. Nister M., Libermann T.A., Betsholtz C., et al. Expression of messenger RNAs for platelet-derived growth factor and transforming growth factor-alpha and their receptors in human malignant glioma cell lines. Cancer Res 48 14 (1988) 3910-3918
53. Hermanson M., Funa K., Hartman M., et al. Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res 52 11 (1992) 3213-3219
54. Di Rocco F., Carroll R.S., Zhang J., et al. Platelet-derived growth factor and its receptor expression in human oligodendrogliomas. Neurosurgery 42 2 (1998) 341-346
55. Varela M., Ranuncolo S.M., Morand A., et al. EGF-R and PDGF-R, but not bcl-2, overexpression predict overall survival in patients with low-grade astrocytomas. J Surg Oncol 86 1 (2004) 34-40
56. Lokker N.A., Sullivan C.M., Hollenbach S.J., et al. Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors. Cancer Res 62 13 (2002) 3729-3735
57. Shapiro J.R. Genetics of nervous system tumors. Hematol Oncol Clin North Am 15 6 (2001) 961-977
58. Fleming T.P., Saxena A., Clark W.C., et al. Amplification and/or overexpression of platelet-derived growth factor receptors and epidermal growth factor receptor in human glial tumors. Cancer Res 52 16 (1992) 4550-4553
59. Smith J.S., Wang X.Y., Qian J., et al. Amplification of the platelet-derived growth factor receptor-A (PDGFRA) gene occurs in oligodendrogliomas with grade IV anaplastic features. J Neuropathol Exp Neurol 59 6 (2000) 495-503
60. Kumabe T., Sohma Y., Kayama T., et al. Overexpression and amplification of alpha-PDGF receptor gene lacking exons coding for a portion of the extracellular region in a malignant glioma. Tohoku J Exp Med 168 2 (1992) 265-269
61. Clarke I.D., and Dirks P.B. A human brain tumor-derived PDGFR-alpha deletion mutant is transforming. Oncogene 22 5 (2003) 722-733
62. Plate K.H., Breier G., Farrell C.L., et al. Platelet-derived growth factor receptor-beta is induced during tumor development and upregulated during tumor progression in endothelial cells in human gliomas. Lab Invest 67 4 (1992) 529-534
63. Maxwell M., Naber S.P., Wolfe H.J., et al. Coexpression of platelet-derived growth factor (PDGF) and PDGF-receptor genes by primary human astrocytomas may contribute to their development and maintenance. J Clin Invest 86 1 (1990) 131-140
64. Shawver L.K., Schwartz D.P., Mann E., et al. Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide. Clin Cancer Res 3 7 (1997) 1167-1177
65. Kilic T., Alberta J.A., Zdunek P.R., et al. Intracranial inhibition of platelet-derived growth factor-mediated glioblastoma cell growth by an orally active kinase inhibitor of the 2-phenylaminopyrimidine class. Cancer Res 60 18 (2000) 5143-5150
66. Farhadi M.R., Capelle H.H., Erber R., et al. Combined inhibition of vascular endothelial growth factor and platelet-derived growth factor signaling: effects on the angiogenesis, microcirculation, and growth of orthotopic malignant gliomas. J Neurosurg 102 2 (2005) 363-370
67. O'Reilly T., Wartmann M., Maira S.M., et al. Patupilone (epothilone B, EPO906) and imatinib (STI571, Glivec) in combination display enhanced antitumour activity in vivo against experimental rat C6 glioma. Cancer Chemother Pharmacol 55 4 (2005) 307-317
68. Uhrbom L., Hesselager G., Nister M., et al. Induction of brain tumors in mice using a recombinant platelet-derived growth factor B-chain retrovirus. Cancer Res 58 23 (1998) 5275-5279
69. Hesselager G., Uhrbom L., Westermark B., et al. Complementary effects of platelet-derived growth factor autocrine stimulation and p53 or Ink4a-Arf deletion in a mouse glioma model. Cancer Res 63 15 (2003) 4305-4309
70. Dai C., Celestino J.C., Okada Y., et al. PDGF autocrine stimulation dedifferentiates cultured astrocytes and induces oligodendrogliomas and oligoastrocytomas from neural progenitors and astrocytes in vivo. Genes Dev 15 15 (2001) 1913-1925
71. Shih A.H., Dai C., Hu X., et al. Dose-dependent effects of platelet-derived growth factor-B on glial tumorigenesis. Cancer Res 64 14 (2004) 4783-4789
72. Heller S., Scheibenpflug L., Westermark B., et al. PDGF B mRNA variants in human tumors with similarity to the v-sis oncogene: expression of cellular PDGF B protein is associated with exon 1 divergence, but not with a 3′ UTR splice variant. Int J Cancer 85 2 (2000) 211-222
73. Liotta L.A., and Kohn E.C. The microenvironment of the tumour-host interface. Nature 411 6835 (2001) 375-379
74. Joyce J.A. Therapeutic targeting of the tumor microenvironment. Cancer Cell 7 6 (2005) 513-520
75. Bjerkvig R., Tysnes B.B., Aboody K.S., et al. Opinion: the origin of the cancer stem cell: current controversies and new insights. Nat Rev Cancer 5 11 (2005) 899-904
76. Abbott N.J., Ronnback L., and Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 7 1 (2006) 41-53
77. Frisch S.M., Vuori K., Ruoslahti E., et al. Control of adhesion-dependent cell survival by focal adhesion kinase. J Cell Biol 134 3 (1996) 793-799
78. Frisch S.M., and Ruoslahti E. Integrins and anoikis. Curr Opin Cell Biol 9 5 (1997) 701-706
79. Colognato H., Ramachandrappa S., Olsen I.M., et al. Integrins direct Src family kinases to regulate distinct phases of oligodendrocyte development. J Cell Biol 167 2 (2004) 365-375
80. Werb Z. ECM and cell surface proteolysis: regulating cellular ecology. Cell 91 4 (1997) 439-442
81. Coussens L.M., Tinkle C.L., Hanahan D., et al. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103 3 (2000) 481-490
82. Bowden E.T., Barth M., Thomas D., et al. An invasion-related complex of cortactin, paxillin and PKCmu associates with invadopodia at sites of extracellular matrix degradation. Oncogene 18 31 (1999) 4440-4449
83. Shain K.H., and Dalton W.S. Cell adhesion is a key determinant in de novo multidrug resistance (MDR): new targets for the prevention of acquired MDR. Mol Cancer Ther 1 1 (2001) 69-78
84. Franca L.C., and Foraker A.G. Interferometric study of astrocytes in gliosis and astrocytoma. Arch Neurol 3 (1960) 416-419
85. Takenaga K., and Kozlova E.N. Role of intracellular S100A4 for migration of rat astrocytes. Glia 53 3 (2006) 313-321
86. Angelastro J.M., Canoll P.D., Kuo J., et al. Selective destruction of glioblastoma cells by interference with the activity or expression of ATF5. Oncogene 25 6 (2006) 907-916
87. Tomakidi P., Mirancea N., Fusenig N.E., et al. Defects of basement membrane and hemidesmosome structure correlate with malignant phenotype and stromal interactions in HaCaT-Ras xenografts. Differentiation 64 5 (1999) 263-275
88. Pollard J.W. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4 1 (2004) 71-78
89. Hanahan D., and Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86 3 (1996) 353-364
90. Carmeliet P. Angiogenesis in health and disease. Nat Med 9 6 (2003) 653-660
91. Rafii S., Lyden D., Benezra R., et al. Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy?. Nat Rev Cancer 2 11 (2002) 826-835
92. Guo P., Hu B., Gu W., et al. Platelet-derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment. Am J Pathol 162 4 (2003) 1083-1093
93. Cao Y. Direct role of PDGF-BB in lymphangiogenesis and lymphatic metastasis. Cell Cycle 4 2 (2005) 228-230
94. Papadopoulos M.C., Saadoun S., Davies D.C., et al. Emerging molecular mechanisms of brain tumour oedema. Br J Neurosurg 15 2 (2001) 101-108
95. Davies D.C. Blood-brain barrier breakdown in septic encephalopathy and brain tumours. J Anat 200 6 (2002) 639-646
96. Liebner S., Fischmann A., Rascher G., et al. Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme. Acta Neuropathol (Berl) 100 3 (2000) 323-331
97. Dvorak H.F., Brown L.F., Detmar M., et al. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146 5 (1995) 1029-1039
98. Vajkoczy P., and Menger M.D. Vascular microenvironment in gliomas. Cancer Treat Res 117 (2004) 249-262
99. Rascher G., Fischmann A., Kroger S., et al. Extracellular matrix and the blood-brain barrier in glioblastoma multiforme: spatial segregation of tenascin and agrin. Acta Neuropathol (Berl) 104 1 (2002) 85-91 [Epub: March 28, 2002]
100. Heldin C.H., Rubin K., Pietras K., et al. High interstitial fluid pressure-an obstacle in cancer therapy. Nat Rev Cancer 4 10 (2004) 806-813
101. Carmeliet P., and Jain R.K. Angiogenesis in cancer and other diseases. Nature 407 6801 (2000) 249-257
102. Pietras K., Sjoblom T., Rubin K., et al. PDGF receptors as cancer drug targets. Cancer Cell 3 5 (2003) 439-443
103. Bhowmick N.A., Chytil A., Plieth D., et al. TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 303 5659 (2004) 848-851
104. Olumi A.F., Grossfeld G.D., Hayward S.W., et al. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 59 19 (1999) 5002-5011
105. Hayashi N., and Cunha G.R. Mesenchyme-induced changes in the neoplastic characteristics of the Dunning prostatic adenocarcinoma. Cancer Res 51 18 (1991) 4924-4930
106. Regina A., Demeule M., Berube A., et al. Differences in multidrug resistance phenotype and matrix metalloproteinases activity between endothelial cells from normal brain and glioma. J Neurochem 84 2 (2003) 316-324
107. Bian X.W., Jiang X.F., Chen J.H., et al. Increased angiogenic capabilities of endothelial cells from microvessels of malignant human gliomas. Int Immunopharmacol 6 1 (2006) 90-99
108. Ludwig A., Schulte A., Schnack C., et al. Enhanced expression and shedding of the transmembrane chemokine CXCL16 by reactive astrocytes and glioma cells. J Neurochem 93 5 (2005) 1293-1303
109. Le D.M., Besson A., Fogg D.K., et al. Exploitation of astrocytes by glioma cells to facilitate invasiveness: a mechanism involving matrix metalloproteinase-2 and the urokinase-type plasminogen activator-plasmin cascade. J Neurosci 23 10 (2003) 4034-4043
110. Reynolds B.A., and Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255 5052 (1992) 1707-1710
111. Lois C., and Alvarez-Buylla A. Proliferating subventricular zone cells in the adult mammalian forebrain can differentiate into neurons and glia. Proc Natl Acad Sci USA 90 5 (1993) 2074-2077
112. McKay R. Stem cells in the central nervous system. Science 276 5309 (1997) 66-71
113. Ming G.L., and Song H. Adult neurogenesis in the mammalian central nervous system. Annu Rev Neurosci 28 (2005) 223-250
114. Nottebohm F. The road we travelled: discovery, choreography, and significance of brain replaceable neurons. Ann NY Acad Sci 1016 (2004) 628-658
115. Eriksson P.S., Perfilieva E., Bjork-Eriksson T., et al. Neurogenesis in the adult human hippocampus. Nat Med 4 11 (1998) 1313-1317
116. Temple S. The development of neural stem cells. Nature 414 6859 (2001) 112-117
117. Doetsch F., Caille I., Lim D.A., et al. Subventricular zone astrocytes are neural stem cells in the adult mammalian brain. Cell 97 6 (1999) 703-716
118. Sanai N., Tramontin A.D., Quinones-Hinojosa A., et al. Unique astrocyte ribbon in adult human brain contains neural stem cells but lacks chain migration. Nature 427 6976 (2004) 740-744
119. Seri B., Garcia-Verdugo J.M., McEwen B.S., et al. Astrocytes give rise to new neurons in the adult mammalian hippocampus. J Neurosci 21 18 (2001) 7153-7160
120. Pagano S.F., Impagnatiello F., Girelli M., et al. Isolation and characterization of neural stem cells from the adult human olfactory bulb. Stem Cells 18 4 (2000) 295-300
121. Gritti A., Bonfanti L., Doetsch F., et al. Multipotent neural stem cells reside into the rostral extension and olfactory bulb of adult rodents. J Neurosci 22 2 (2002) 437-445
122. Alvarez-Buylla A., Seri B., and Doetsch F. Identification of neural stem cells in the adult vertebrate brain. Brain Res Bull 57 6 (2002) 751-758
123. Wong A.M., Hodges H., and Horsburgh K. Neural stem cell grafts reduce the extent of neuronal damage in a mouse model of global ischaemia. Brain Res 1063 2 (2005) 140-150
124. Zhang P.B., Liu Y., Li J., et al. Ependymal/subventricular zone cells migrate to the peri-infarct region and differentiate into neurons and astrocytes after focal cerebral ischemia in adult rats. Di Yi Jun Yi Da Xue Xue Bao 25 10 (2005) 1201-1206
125. Takagi Y., Nishimura M., Morizane A., et al. Survival and differentiation of neural progenitor cells derived from embryonic stem cells and transplanted into ischemic brain. J Neurosurg 103 2 (2005) 304-310
126. Felling R.J., Snyder M.J., Romanko M.J., et al. Neural stem/progenitor cells participate in the regenerative response to perinatal hypoxia/ischemia. J Neurosci 26 16 (2006) 4359-4369
127. Tonchev A.B., Yamashima T., Sawamoto K., et al. Enhanced proliferation of progenitor cells in the subventricular zone and limited neuronal production in the striatum and neocortex of adult macaque monkeys after global cerebral ischemia. J Neurosci Res 81 6 (2005) 776-788
128. Imitola J., Raddassi K., Park K.I., et al. Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc Natl Acad Sci USA 101 52 (2004) 18117-18122
129. Takemura S., Kayama T., Kuge A., et al. Correlation between copper/zinc superoxide dismutase and the proliferation of neural stem cells in aging and following focal cerebral ischemia. J Neurosurg 104 1 (2006) 129-136
130. Zhu W., Mao Y., and Zhou L.F. Reduction of neural and vascular damage by transplantation of VEGF-secreting neural stem cells after cerebral ischemia. Acta Neurochir Suppl (Wien) 95 (2005) 393-397
131. Chu K., Park K.I., Lee S.T., et al. Combined treatment of vascular endothelial growth factor and human neural stem cells in experimental focal cerebral ischemia. Neurosci Res 53 4 (2005) 384-390
132. Kawada H., Takizawa S., Takanashi T., et al. Administration of hematopoietic cytokines in the subacute phase after cerebral infarction is effective for functional recovery facilitating proliferation of intrinsic neural stem/progenitor cells and transition of bone marrow-derived neuronal cells. Circulation 113 5 (2006) 701-710
133. Buffo A., Vosko M.R., Erturk D., et al. Expression pattern of the transcription factor Olig2 in response to brain injuries: implications for neuronal repair. Proc Natl Acad Sci USA 102 50 (2005) 18183-18188 [Epub: December 5, 2005]
134. Givogri M.I., de Planell M., Galbiati F., et al. Notch signaling in astrocytes and neuroblasts of the adult subventricular zone in health and after cortical injury. Dev Neurosci 28 1-2 (2006) 81-91
135. Pei D.S., Wang X.T., Liu Y., et al. Neuroprotection against ischaemic brain injury by a GluR6-9c peptide containing the TAT protein transduction sequence. Brain 129 Pt 2 (2006) 465-479
136. Guan Q.H., Pei D.S., Zong Y.Y., et al. Neuroprotection against ischemic brain injury by a small peptide inhibitor of c-Jun N-terminal kinase (JNK) via nuclear and non-nuclear pathways. Neuroscience 139 2 (2006) 609-627
137. Shin W.H., Park S.J., and Kim E.J. Protective effect of anthocyanins in middle cerebral artery occlusion and reperfusion model of cerebral ischemia in rats. Life Sci 79 2 (2006) 130-137
138. Herrmann O., Baumann B., de Lorenzi R., et al. IKK mediates ischemia-induced neuronal death. Nat Med 11 12 (2005) 1322-1329
139. Culmsee C., Siewe J., Junker V., et al. Reciprocal inhibition of p53 and nuclear factor-kappaB transcriptional activities determines cell survival or death in neurons. J Neurosci 23 24 (2003) 8586-8595
140. Bright R., and Mochly-Rosen D. The role of protein kinase C in cerebral ischemic and reperfusion injury. Stroke 36 12 (2005) 2781-2790
141. Collino M., Aragno M., Mastrocola R., et al. Modulation of the oxidative stress and inflammatory response by PPAR-gamma agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion. Eur J Pharmacol 530 1-2 (2006) 70-80
142. Liu R., Suzuki A., Guo Z., et al. Intrinsic and extrinsic erythropoietin enhances neuroprotection against ischemia and reperfusion injury in vitro. J Neurochem 96 4 (2006) 1101-1110
143. Sun N., Zou X., Shi J., et al. Electroacupuncture regulates NMDA receptor NR1 subunit expression via PI3-K pathway in a rat model of cerebral ischemia-reperfusion. Brain Res 1064 1-2 (2005) 98-107
144. Malhotra S., Savitz S.I., Ocava L., et al. Ischemic preconditioning is mediated by erythropoietin through PI-3 kinase signaling in an animal model of transient ischemic attack. J Neurosci Res 83 1 (2006) 19-27
145. Kilic E., Kilic U., Soliz J., et al. Brain-derived erythropoietin protects from focal cerebral ischemia by dual activation of ERK-1/-2 and Akt pathways. FASEB J 19 14 (2005) 2026-2028
146. Yamashita T., Sawamoto K., Suzuki S., et al. Blockade of interleukin-6 signaling aggravates ischemic cerebral damage in mice: possible involvement of Stat3 activation in the protection of neurons. J Neurochem 94 2 (2005) 459-468
147. Jiang W., Van Cleemput J., Sheerin A.H., et al. Involvement of extracellular regulated kinase and p38 kinase in hippocampal seizure tolerance. J Neurosci Res 81 4 (2005) 581-588
148. Ahmad M., Saleem S., Zhuang H., et al. 1-hydroxy PGE reduces infarction volume in mouse transient cerebral ischemia. Eur J Neurosci 23 1 (2006) 35-42
149. Asano T., Mori T., Shimoda T., et al. Arundic acid (ONO-2506) ameliorates delayed ischemic brain damage by preventing astrocytic overproduction of S100B. Curr Drug Targets CNS Neurol Disord 4 2 (2005) 127-142
150. Aboody K.S., Brown A., Rainov N.G., et al. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc Natl Acad Sci USA 97 23 (2000) 12846-12851 [Erratum: Proc Natl Acad Sci USA 2001;98(2):777]
151. Herrlinger U., Woiciechowski C., Sena-Esteves M., et al. Neural precursor cells for delivery of replication-conditional HSV-1 vectors to intracerebral gliomas. Mol Ther 1 4 (2000) 347-357
152. Ehtesham M., Kabos P., Kabosova A., et al. The use of interleukin 12-secreting neural stem cells for the treatment of intracranial glioma. Cancer Res 62 20 (2002) 5657-5663
153. Ehtesham M., Kabos P., Gutierrez M.A., et al. Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand. Cancer Res 62 24 (2002) 7170-7174
154. Brown A.B., Yang W., Schmidt N.O., et al. Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin. Hum Gene Ther 14 18 (2003) 1777-1785
155. Schmidt N.O., Przylecki W., Yang W., et al. Brain tumor tropism of transplanted human neural stem cells is induced by vascular endothelial growth factor. Neoplasia 7 6 (2005) 623-629
156. Ziu M., Schmidt N.O., Cargioli T.G., et al. Glioma-produced extracellular matrix influences brain tumor tropism of human neural stem cells. J Neurooncol 79 2 (2006) 125-133
157. Glass R., Synowitz M., Kronenberg G., et al. Glioblastoma-induced attraction of endogenous neural precursor cells is associated with improved survival. J Neurosci 25 10 (2005) 2637-2646
158. Ehtesham M., Yuan X., Kabos P., et al. Glioma tropic neural stem cells consist of astrocytic precursors and their migratory capacity is mediated by CXCR4. Neoplasia 6 3 (2004) 287-293
159. Sanai N., Alvarez-Buylla A., and Berger M.S. Neural stem cells and the origin of gliomas. N Engl J Med 353 8 (2005) 811-822
160. Reya T., Morrison S.J., Clarke M.F., et al. Stem cells, cancer, and cancer stem cells. Nature 414 6859 (2001) 105-111
161. Singh S.K., Hawkins C., Clarke I.D., et al. Identification of human brain tumour initiating cells. Nature 432 (2004) 396-401
162. Hemmati H.D., Nakano I., Lazareff J.A., et al. Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci USA 100 (2003) 15178-15183
163. Yuan X., Curtin J., Xiong Y., et al. Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene 23 58 (2004) 9392-9400
164. Galli R., Binda E., Orfanelli U., et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 64 19 (2004) 7011-7021
165. Singh S.K., Clarke I.D., Hide T., et al. Cancer stem cells in nervous system tumors. Oncogene 23 43 (2004) 7267-7273
166. Hopewell J.W., and Wright E.A. The importance of implantation site in cerebral carcinogenesis in rats. Cancer Res 29 11 (1969) 1927-1931
167. Vick N.A., Lin M.J., and Bigner D.D. The role of the subependymal plate in glial tumorigenesis. Acta Neuropathol (Berl) 40 1 (1977) 63-71
168. Berger F., Gay E., Pelletier L., et al. Development of gliomas: potential role of asymmetrical cell division of neural stem cells. Lancet Oncol 5 8 (2004) 511-514
169. Zhu Y., Guignard F., Zhao D., et al. Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma. Cancer Cell 8 2 (2005) 119-130
170. Holland E.C., Celestino J., Dai C., et al. Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat Genet 25 (2000) 55-57
171. Lassman A.B., Dai C., Fuller G.N., et al. Overexpression of c-MYC promotes an undifferentiated phenotype in cultured astrocytes and allows elevated Ras and Akt signaling to induce gliomas from GFAP-expressing cells in mice. Neuron Glia Biol 1 (2005) 157-163
172. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 1 (2000) 57-70
173. Lu P., Blesch A., and Tuszynski M.H. Induction of bone marrow stromal cells to neurons: differentiation, transdifferentiation, or artifact?. J Neurosci Res 77 2 (2004) 174-191
174. Alvarez-Dolado M., Pardal R., Garcia-Verdugo J.M., et al. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 425 6961 (2003) 968-973
175. Vescovi A., Gritti A., Cossu G., et al. Neural stem cells: plasticity and their transdifferentiation potential. Cells Tissues Organs 171 1 (2002) 64-76
176. Wells W.A. Is transdifferentiation in trouble?. J Cell Biol 157 1 (2002) 15-18
177. Doetsch F., Petreanu L., Caille I., et al. EGF converts transit-amplifying neurogenic precursors in the adult brain into multipotent stem cells. Neuron 36 6 (2002) 1021-1034
178. Hu X., Pandolfi P.P., Li Y., et al. mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma. Neoplasia 7 4 (2005) 356-368
179. Paulus W., Lisle D.K., Tonn J.C., et al. Molecular genetic alterations in pleomorphic xanthoastrocytoma. Acta Neuropathol (Berl) 91 3 (1996) 293-297